In this section, we provide users of our information portal with a further, now very extensive option for carrying out research and analyses on listed companies. The module offers a wide range of setting options as well as a number of useful additional features that make your work easier when analyzing companies. You also save valuable time, as further information is just a click away.
The intelligent search function allows you to search by WKN, ISIN, symbol or the name of the company. The database is constantly being expanded. If you would like to refer to a specific chart, you are welcome to use the short URL provided. With one click you can copy it to the clipboard and link it via e-mail or social media. The integrated AI provides you with further information on the individual companies. Simply click on the small OpenAI symbol and wait for the result of the AI analysis. Tip: Switch to the *Advanced version* to display the professional view of the charting.
This overview is updated on an ongoing basis. It shows the companies for which news is available from selected stock exchange operators - in this case NASDAQ Nordic via GlobeNewsWire. This may include corporate actions, information on dividends, but also products and many other types of company-relevant information. If you are in the chart view (360°), you can easily jump from there to the respective news item and carry out further research. All news across products and events can be found in the X-Feed Billboard (International).
REYKJAVIK, Iceland and LONDON, June 18, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma, a UK headquartered global pharmaceutical company with a strategic focus on specialty, hospital, and rare disease medicines in Europe, today announced that the companies have entered into an exclusive partnership agreement regarding the supply and commercialization of Alvotech’s proposed biosimilar to Eylea® (aflibercept). Alvotech is currently developing AVT06, a proposed biosimilar to Eylea® low dose (2 mg) and AVT29, a biosimilar candidate for Eylea® high dose (8 mg).
REYKJAVIK, ICELAND and LONDON, UK (June 18, 2024) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma, a UK headquartered global pharmaceutical company with a strategic focus on specialty, hospital, and rare disease medicines in Europe, today announced that the companies have entered into an exclusive partnership agreement regarding the supply and commercialization of Alvotech’s proposed biosimilar to Eylea® (aflibercept). Alvotech is currently developing AVT06, a proposed biosimilar to Eylea® low dose (2 mg) and AVT29 a biosimilar candidate for Eylea® high dose (8 mg).
Press release
Nokia and Google Cloud collaborate to help developers worldwide create 5G applications faster with telco APIs
Tokyo, Japan and Cambridge, UK, 18 June 2024 – Nxera Pharma (“Nxera” or “the Company”; TSE 4565), today announces the publication of its Annual Report and its Environment, Social & Governance (ESG) Report for the year ended 31 December 2023.
SHANGHAI, June 18, 2024 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the National Medical Products Administration (NMPA) has approved the supplemental new drug application (sNDA) for toripalimab (product code: JS001) in combination with etoposide plus platinum for the first-line treatment of extensive-stage small cell lung cancer (ES-SCLC).
Noted Economist Gordon Rausser elaborates on investment strategies in the growing green hydrogen market
NASDAQ Copenhagen A/S
Halifax, NS – 18 June 2024 – Atlantic Towing Limited, a member of the J.D. Irving, Limited family of companies and Svitzer have made a significant joint investment in the modernisation of the Port of Halifax fleet by acquiring two new escort tugboats from the Rastar 3200 series, each boasting an 85-ton bollard pull.
Press Release
Meriaura Group Plc
Company announcement, Major holdings 18.6.2024 klo 9.00 (CEST)
Der anmodes om ophør af suspension for afdelinger nedenfor.
CHEOPS TECHNOLOGY FRANCHIT LE CAP DES 200 MILLIONS D’EUROS DE CHIFFRE D’AFFAIRES CONSOLIDÉ
Clean Motion meddelade den 13 juni 2024 att de har tecknat en avsiktsförklaring om ett förvärv av EVX Mobility Sweden AB genom en apportemission. Förvärvet ses som strategiskt för att stärka Clean Motions position på marknaden för lätta elfordon då det breddar bolagets sortiment med större fyrhjuliga fordon. Förvärvet accelererar företagets tillväxtplaner genom marknadsintroduktion av bland annat arbetsfordon och fordon för hotell, park och resorts, på flera nya marknader. Förvärvet adderar flera nya försäljningsklara fordonsmodeller och man ser att förvärvet kommer generera korsförsäljning till gemensamma såväl som nya kunder inom alla produktkategorier. Clean Motion ser att detta förvärv förväntas generera ett avsevärt aktieägarvärde och intäkter i närtid. Prognosen för orderingången på EVX-fordonsmodeller 2024 är 36 miljoner kronor samt 260 miljoner kronor för 2025.
René van Vlerken to succeed Simone Huis in ‘t Veld as CEO of Euronext Amsterdam
In company announcement no. 10 2024, Spar Nord announced a share buyback programme of up to DKK 500 million. The share buyback was initiated on 12 February 2024.
Notes on the functional elements
Badge 'News Explorer' - Functional element to open navigation panel